We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




PICC Use Increases Risk of Dangerous Blood Clots

By HospiMedica International staff writers
Posted on 29 May 2013
A new study suggests that peripherally inserted central catheters (PICCs) more than double the risk of venous thromboembolism (VT) when compared to other central venous catheters (CVCs).

Researchers at the University of Michigan Health System (Ann Arbor, USA) conducted a search of Medline, Embase, Biosis, the Cochrane Central Register of Controlled Trials, Conference Papers Index, and other human studies published in full text, abstract, or poster form. More...
All studies were of adult patients aged at least 18 years who underwent insertion of a PICC; in studies without a comparison group, the pooled frequency of VT was calculated for patients receiving PICCs. In studies comparing PICCs with other CVCs, summary odds ratios (ORs) were calculated with a random effects meta-analysis.

The results showed that of the 533 citations identified, 64 studies (12 with a comparison group and 52 without) including 29,503 patients met the eligibility criteria. In the noncomparison studies, the weighted frequency of PICC-related deep vein thrombosis was highest in patients who were critically ill and those with cancer. A meta-analysis of 11 studies comparing the risk of deep vein VT related to PICCs, with that related to CVCs, showed that PICCs were associated with an increased risk of deep vein thrombosis (OR 2.55), but not pulmonary embolism (PE). The study was published early online on May 20, 2013, in the Lancet.

“Peripherally inserted central catheters have ushered in a new era of care and certainly the benefits of these devices are significant. We’ve gravitated towards using this device over central venous catheters for good reasons, and it may still be the best choice for some people,” said lead author Vineet Chopra, MD, an assistant professor of internal medicine. “Our findings suggest that patients and physicians should carefully review the risks and benefits when it comes to placing PICCs, especially with respect to blood clots. There is no one-size-fits-all approach when considering use of these devices.”

PICCs have become the preferred device through which to administer long-term intravenous (IV) fluids, antibiotics, and other drugs because they have lower risks of infection, they can be conveniently placed at the bedside, and can stay in place for long periods. PICCs are also safer to insert, typically placed in the arm, while CVCs are placed into a large vein in the neck, chest, or groin and risk damage to nerves or arteries. The ability to keep PICCs in for weeks or even months also allows patients who need a constant flow of medications to go home with these catheters.

Related Links:

University of Michigan Health System



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.